Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.

Wen OuyangConghua XieShuake NuerjiangZhijun LiDajiang WangXiaoyong WangJunhong ZhangConghua Xie

Published in: Cancer medicine (2019)

SBRT for pulmonary lesions was a feasible and tolerable option for oligometastatic NSCLC patients. Delivery of SBRT for pulmonary lesions improved outcomes of oligometastatic NSCLC patients. Finally, SBRT combined with first line target therapy might have optimal outcomes.

Keyphrases

end stage renal disease
radiation therapy
newly diagnosed
ejection fraction
chronic kidney disease
pulmonary hypertension
early stage
type diabetes
squamous cell carcinoma
metabolic syndrome
advanced non small cell lung cancer
radiation induced
skeletal muscle